The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Prognostic Value of PLR in Various Cancers: A Meta-Analysis
Open accessAbstract
BACKGROUND: Recently, more and more studies investigated the association of inflammation parameters such as the Platelet Lymphocyte Ratio (PLR) and the prognosis of various cancers. However, the prognostic role of PLR in cancer remains controversial. METHODS: We conducted a meta-analysis of published studies to evaluate the prognostic value of PLR in various cancers. In order to investigate the association between PLR and overall survival (OS), the hazard ratio (HR) and its 95% confidence interval (CI) were calculated. RESULTS: A total of 13,964 patients from 26 studies were included in the analysis. The summary results showed that elevated PLR was a negative predictor for OS with HR of 1.60 (95%CI: 1.35-1.90; Pheterogeneity <0.001). Subgroup analysis revealed that increased PLR was a negative prognostic marker in patients with gastric cancer (HR = 1.35, 95%CI: 0.80-2.25, Pheterogeneity = 0.011), colorectal cancer (HR = 1.65, 95%CI: 1.33-2.05, Pheterogeneity = 0.995), hepatocellular carcinoma (HR = 3.07, 95% CI: 2.04-4.62, Pheterogeneity = 0.133), ovarian cancer (HR = 1.57, 95%CI: 1.07-2.31, Pheterogeneity = 0.641) and non-small cell lung cancer (NSCLC) (HR = 1.85, 95% CI: 1.42-2.41, Pheterogeneity = 0.451) except for pancreatic cancer (HR = 1.00, 95%CI: 0.92-1.09, Pheterogeneity = 0.388). CONCLUSION: The meta-analysis demonstrated that PLR could act as a significant biomarker in the prognosis of various cancers.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Meta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552
Liberati, A., Altman, D. G., Tetzlaff, J., Mulrow, C., Gøtzsche, P. C., Ioannidis, J. P. A., Clarke, M., Devereaux, P. J., Kleijnen, J., & Moher, D. (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000100 · Cited by 28,164
Meta-analysis of Observational Studies in Epidemiology<SUBTITLE>A Proposal for Reporting</SUBTITLE>
Stroup, D. F. (2000) · JAMA · doi:10.1001/jama.283.15.2008 · Cited by 20,623
Statistical Aspects of the Analysis of Data From Retrospective Studies of Disease
(1959) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/22.4.719 · Cited by 14,689 · cited 1×
“Otherwise, the fixed-effects model (MantelHaenszel method) was applied [15].”
MethodSiegel, R., Naishadham, D., & Jemal, A. (2013) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21166 · Cited by 11,825
Mantovani, A., Allavena, P., Sica, A., & Balkwill, F. (2008) · Nature · doi:10.1038/nature07205 · Cited by 11,399
Immunity, Inflammation, and Cancer
Grivennikov, S. I., Greten, F. R., & Karin, M. (2010) · Cell · doi:10.1016/j.cell.2010.01.025 · Cited by 10,755
Inflammation and cancer: back to Virchow?
Balkwill, F., & Mantovani, A. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04046-0 · Cited by 7,746
Macrophage Diversity Enhances Tumor Progression and Metastasis
Qian, B.-Z., & Pollard, J. W. (2010) · Cell · doi:10.1016/j.cell.2010.03.014 · Cited by 5,188
Parmar, M. K. B., Torri, V., & Stewart, L. (1998) · Statistics in Medicine · doi:10.1002/(sici)1097-0258(19981230)17:24<2815::aid-sim110>3.0.co;2-8 · Cited by 4,802
The Immunobiology of Cancer Immunosurveillance and Immunoediting
Dunn, G. P., Old, L. J., & Schreiber, R. D. (2004) · Immunity · doi:10.1016/j.immuni.2004.07.017 · Cited by 3,032
Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability
Colotta, F., Allavena, P., Sica, A., Garlanda, C., & Mantovani, A. (2009) · Carcinogenesis · doi:10.1093/carcin/bgp127 · Cited by 2,890
Cancer regression in patients after transfer of genetically engineered lymphocytes
Morgan, R. A., Dudley, M. E., Wunderlich, J. R., Hughes, M. S., Yang, J. C., Sherry, R. M., Royal, R. E., Topalian, S. L., Kammula, U. S., Restifo, N. P., et al. (2006) · Science · doi:10.1126/science.1129003 · Cited by 2,603
Paradoxical roles of the immune system during cancer development
de Visser, K. E., Eichten, A., & Coussens, L. M. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1782 · Cited by 2,256
Tumor-Infiltrating CD8+Lymphocytes Predict Clinical Outcome in Breast Cancer
Mahmoud, S. M. A., Paish, E. C., Powe, D. G., Macmillan, R. D., Grainge, M. J., Lee, A. H. S., Ellis, I. O., & Green, A. R. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.30.5037 · Cited by 1,367
Systemic inflammation, nutritional status and survival in patients with cancer
McMillan, D. C. (2009) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/mco.0b013e32832a7902 · Cited by 1,001
Proctor, M. J., Morrison, D. S., Talwar, D., Balmer, S. M., Fletcher, C. D., O’Reilly, D. S. J., Foulis, A. K., Horgan, P. G., & McMillan, D. C. (2011) · European Journal of Cancer · doi:10.1016/j.ejca.2011.03.028 · Cited by 757
The platelet contribution to cancer progression
BAMBACE, N. M., & HOLMES, C. E. (2011) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2010.04131.x · Cited by 705
Tumour immunity: effector response to tumour and role of the microenvironment
Mantovani, A., Romero, P., Palucka, A. K., & Marincola, F. M. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60241-x · Cited by 537
Review: Role of Blood Platelets in Infection and Inflammation
Klinger, M. H. F., & Jelkmann, W. (2002) · Journal of Interferon & Cytokine Research · doi:10.1089/10799900260286623 · Cited by 505
Stotz, M., Gerger, A., Eisner, F., Szkandera, J., Loibner, H., L Ress, A., Kornprat, P., A Zoughbi, W., Seggewies, F. S., Lackner, C., et al. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.332 · Cited by 490
Kwon, H.-C., Kim, S. H., Oh, S. Y., Lee, S., Lee, J. H., Choi, H.-J., Park, K.-J., Roh, M. S., Kim, S.-G., Kim, H.-J., et al. (2012) · Biomarkers · doi:10.3109/1354750x.2012.656705 · Cited by 409
Bhatti, I., Peacock, O., Lloyd, G., Larvin, M., & Hall, R. I. (2010) · The American Journal of Surgery · doi:10.1016/j.amjsurg.2009.08.041 · Cited by 333
Platelets and Angiogenesis in Malignancy
(2004) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-2004-822974 · Cited by 315
Kinoshita, A., Onoda, H., Imai, N., Iwaku, A., Oishi, M., Fushiya, N., Koike, K., Nishino, H., & Tajiri, H. (2012) · British Journal of Cancer · doi:10.1038/bjc.2012.354 · Cited by 293
Cedrés, S., Torrejon, D., Martínez, A., Martinez, P., Navarro, A., Zamora, E., Mulet-Margalef, N., & Felip, E. (2012) · Clinical and Translational Oncology · doi:10.1007/s12094-012-0872-5 · Cited by 293
Poor prognosis associated with thrombocytosis in patients with gastric cancer
Ikeda, M., Furukawa, H., Imamura, H., Shimizu, J., Ishida, H., Masutani, S., Tatsuta, M., & Satomi, T. (2002) · Annals of Surgical Oncology · doi:10.1007/bf02573067 · Cited by 292
Lee, S., Oh, S. Y., Kim, S. H., Lee, J. H., Kim, M. C., Kim, K. H., & Kim, H.-J. (2013) · BMC Cancer · doi:10.1186/1471-2407-13-350 · Cited by 281
Decreased Total Lymphocyte Counts in Pancreatic Cancer: An Index of Adverse Outcome
Fogar, P., Sperti, C., Basso, D., Sanzari, M. C., Greco, E., Davoli, C., Navaglia, F., Zambon, C.-F., Pasquali, C., Venza, E., et al. (2006) · Pancreas · doi:10.1097/01.mpa.0000188305.90290.50 · Cited by 260
Azab, B., Shah, N., Radbel, J., Tan, P., Bhatt, V., Vonfrolio, S., Habeshy, A., Picon, A., & Bloom, S. (2013) · Medical Oncology · doi:10.1007/s12032-012-0432-4 · Cited by 249
Platelet to lymphocyte ratio as a prognostic factor for epithelial ovarian cancer
Raungkaewmanee, S., Tangjitgamol, S., Manusirivithaya, S., Srijaipracharoen, S., & Thavaramara, T. (2012) · Journal of Gynecologic Oncology · doi:10.3802/jgo.2012.23.4.265 · Cited by 246
Preoperative platelet lymphocyte ratio as an independent prognostic marker in ovarian cancer
Asher, V., Lee, J., Innamaa, A., & Bali, A. (2011) · Clinical and Translational Oncology · doi:10.1007/s12094-011-0687-9 · Cited by 238
Wang, D.-S., Luo, H.-Y., Qiu, M.-Z., Wang, Z.-Q., Zhang, D.-S., Wang, F.-H., Li, Y.-H., & Xu, R.-H. (2012) · Medical Oncology · doi:10.1007/s12032-012-0226-8 · Cited by 224
Laird, B. J., Kaasa, S., McMillan, D. C., Fallon, M. T., Hjermstad, M. J., Fayers, P., & Klepstad, P. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-1066 · Cited by 211
Alexandrakis, M. G., Passam, F. H., Moschandrea, I. A., Christophoridou, A. V., Pappa, C. A., Coulocheri, S. A., & Kyriakou, D. S. (2003) · American Journal of Clinical Oncology · doi:10.1097/00000421-200304000-00007 · Cited by 198
He, W., Yin, C., Guo, G., Jiang, C., Wang, F., Qiu, H., Chen, X., Rong, R., Zhang, B., & Xia, L. (2013) · Medical Oncology · doi:10.1007/s12032-012-0439-x · Cited by 187
Pinato, D. J., Stebbing, J., Ishizuka, M., Khan, S. A., Wasan, H. S., North, B. V., Kubota, K., & Sharma, R. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.06.022 · Cited by 181
Sánchez-Lara, K., Turcott, J. G., Juárez, E., Guevara, P., Núñez-Valencia, C., Oñate-Ocaña, L. F., Flores, D., & Arrieta, O. (2012) · Nutrition and Cancer · doi:10.1080/01635581.2012.668744 · Cited by 164
Markers of systemic inflammation predict survival in patients with advanced renal cell cancer
Fox, P., Hudson, M., Brown, C., Lord, S., Gebski, V, De Souza, P., & Lee, C. K. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.300 · Cited by 161
Unal, D., Eroğlu, C., Kurtul, N., Oğuz, A., & Taşdemir, A. (2013) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2013.14.9.5237 · Cited by 157
Carruthers, R., Tho, L. M., Brown, J., Kakumanu, S., McCartney, E., & McDonald, A. C. (2012) · Colorectal Disease · doi:10.1111/j.1463-1318.2012.03147.x · Cited by 152
Inflammation-Based Prognostic Indices in Malignant Pleural Mesothelioma
Pinato, D. J., Mauri, F. A., Ramakrishnan, R., Wahab, L., Lloyd, T., & Sharma, R. (2012) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e31823f45c1 · Cited by 150
Smith, R. A., Ghaneh, P., Sutton, R., Raraty, M. G. T., Campbell, F., & Neoptolemos, J. P. (2008) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-008-0554-3 · Cited by 142
Son, H., Park, J. W., Chang, H. J., Kim, D. Y., Kim, B. C., Kim, S. Y., Park, S. C., Choi, H. S., & Oh, J. H. (2013) · Annals of Surgical Oncology · doi:10.1245/s10434-013-2968-8 · Cited by 133
Aliustaoğlu, M., Bilici, A. E., Ustaalıoğlu, B. B. Ö., Konya, V., Gücün, M., Şeker, M., & Gümüş, M. (2009) · Medical Oncology · doi:10.1007/s12032-009-9335-4 · Cited by 128
Kinoshita, A., Onoda, H., Imai, N., Iwaku, A., Oishi, M., Tanaka, K., Fushiya, N., Koike, K., Nishino, H., Matsushima, M., et al. (2013) · BMC Cancer · doi:10.1186/1471-2407-13-52 · Cited by 122
Smith, R. A., Bosonnet, L., Ghaneh, P., Sutton, R., Evans, J., Healey, P. R., Garvey, C., Hughes, M., Raraty, M. G. T., Campbell, F., et al. (2008) · Surgery · doi:10.1016/j.surg.2007.12.014 · Cited by 122
Wang, D., Ren, C., Qiu, M., Luo, H., Wang, Z., Zhang, D.-S., Wang, F.-H., Li, Y.-H., & Xu, R. (2011) · Tumor Biology · doi:10.1007/s13277-011-0285-z · Cited by 122
Szkandera, J., Pichler, M., Absenger, G., Stotz, M., Arminger, F., Weissmueller, M., Schaberl-Moser, R., Samonigg, H., Kornprat, P., Stojaković, T., et al. (2014) · The American Journal of Surgery · doi:10.1016/j.amjsurg.2013.10.030 · Cited by 106
Brown, K. M., Domin, C., Aranha, G. V., Yong, S. L., & Shoup, M. C. (2005) · The American Journal of Surgery · doi:10.1016/j.amjsurg.2004.11.014 · Cited by 88
Paul, D., Kumar, A., Gajbhiye, A., Santra, M. K., & Srikanth, R. (2013) · BioMed Research International · doi:10.1155/2013/783131 · Cited by 65
Wang, D., Wu, M. P., Feng, F., Huang, H., Yang, J., Shen, K., & XIANG, Y. (2013) · Chinese Medical Journal · doi:10.3760/cma.j.issn.0366-6999.20122672 · Cited by 41
Cited by
Fest, J., Ruiter, R., Ikram, M. A., Voortman, T., van Eijck, C. H. J., & Stricker, B. H. (2018) · Scientific Reports · doi:10.1038/s41598-018-28646-w · Cited by 297
Islam, M. M., Satici, M. O., & Eroglu, S. E. (2024) · Turkish Journal of Emergency Medicine · doi:10.4103/tjem.tjem_198_23 · Cited by 255
Metadata
- Authors
- Zhou, X., Du, Y., Huang, Z., Xu, J., Qiu, T., Wang, J., Wang, T., Zhu, W., & Liu, P.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2014-06-26
- Volume
- 9
- Issue
- 6
- Pages
- e101119
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W2061308781
- Cited by
- 330
- References
- 53
- FWCI
- 3.61
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.